Eric Lefkofsky is no stranger to success. Co- founder and chairman of Groupon, and co-founder of the leading provider of integrated media procurement technology, Mediaocean, he has found infinite success in technology and using technology to help people and make the lives of others easier. He is currently CEO of Tempus, which is a technology company that contains the world’s largest library of clinical molecular data and a system that makes data accessible and useful to physicians. Tempus was built to use historical data to help with treatment of terminal illnesses, with cancer as its priority.
Lefkofsky is a strong believer in making big strides in industries that have otherwise remained stagnant and consistent as revealed in his book Accelerated Disruption: Understanding the True Speed of Innovation. In this book, Lefkofsky emphasizes the importance of choosing the right industries to innovate and developing right strategies. These techniques are what led him to earning $1.79 billion over the years in technology innovation within e-commerce and startups. His history with these publicly-traded companies has brought him to the point of being able to create Tempus for the betterment of society and to disrupt the medical industry as we all know it.
Prior to the creation of Tempus, Lefkofsky noticed that the technology was advancing in all other industries except for the most important one—the medical industry. Physicians were collecting large amounts of data on patients dealing with terminal illnesses without having a way to properly analyze it in a way that will help other patients with similar symptoms in the future. Other startups have stepped in to try to improve the medical industry through technology, but Tempus has the industrial connections and capital to make a big difference.
Eric Lefkofsky has successfully been able to communicate with prestigious hospitals and partner with them in hopes of obtaining immense amounts of data. They have also secured lab space in which they will be able to perform tests for gene-sequencing. With the software provided by Tempus, physicians will be able to use the data to make analyses to assist with treatment for a large number of future patients.
To Know More Click Here